Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Dec 1;17(12):1136-1141.
doi: 10.1016/j.jamda.2016.08.004. Epub 2016 Sep 17.

Enhancing SARC-F: Improving Sarcopenia Screening in the Clinical Practice

Affiliations

Enhancing SARC-F: Improving Sarcopenia Screening in the Clinical Practice

Thiago Gonzalez Barbosa-Silva et al. J Am Med Dir Assoc. .

Abstract

Objectives: To validate the (Brazilian) Portuguese-translated version of the SARC-F questionnaire and to verify its performance in the separate sarcopenia screening and muscle function evaluation contexts. In addition, by associating SARC-F to an anthropometric measurement (as an estimate of muscle mass), to test for improvements in its sarcopenia screening efficacy.

Design: Cross-sectional study.

Setting: Urban population of Pelotas, a middle-sized city in Southern Brazil.

Participants: Subsample of 179 community-dwelling elderly aged 60 years or older derived from a population-based study (COMO VAI?).

Measurements: Sarcopenia was evaluated using the European Working Group on Sarcopenia in Older People's diagnostic criteria: dual-energy X-ray absorptiometry, handgrip strength, and walking speed test. Participants also completed SARC-F and their calf circumference (CC) was measured. SARC-F and CC were combined into an original score. The questionnaires' performances were evaluated through receiver operating characteristic curves, sensitivity/specificity analyses, and Pearson χ2.

Results: Sarcopenia was identified in 15 (8.4%) participants by the European Working Group on Sarcopenia in Older People's criteria. Areas under the receiver operating characteristic curves of SARC-F were 0.592 (95% confidence interval (CI) 0.445, 0.739) screening for sarcopenia and 0.779 (95% CI 0.710, 0.846) evaluating muscle function (P < .001). The SARC-F+CC association significantly improved SARC-F's sarcopenia screening performance [area under the curve: 0.736 (95% CI 0.575, 0.897); comparing with SARC-F alone: P = .027]. A substantial improvement in sensitivity was achieved without compromising the remaining parameters.

Conclusions: Despite the satisfactory performance evaluating muscle function, SARC-F alone has not achieved adequate results as a sarcopenia screening tool. However, the SARC-F+CC association significantly improved SARC-F's sarcopenia screening performance, enabling its use in the clinical practice.

Keywords: Sarcopenia; body composition; calf circumference; muscle mass; screening; validation study.

PubMed Disclaimer

Publication types

LinkOut - more resources